| Name | sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
| Description | Involved in negative regulation of fibroblast growth factor receptor signaling pathway. Located in Golgi apparatus; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSPRY1 is a multifaceted regulator of receptor tyrosine kinase–mediated signaling whose activity can be either inhibitory or, in select contexts, positive‐modulatory. Early studies revealed that full‐length SPRY1 (and its splice variants) can potentiate mitogen‐activated protein kinase (MAPK) activation via sequestration of key ubiquitin ligases, while its conserved C‐terminal domain can mediate inhibition of growth factor–induced signaling. These functions are critical during development—for example, in fetal brain patterning, placental branching morphogenesis, and telencephalic cortical differentiation—highlighting an evolutionarily conserved role in fine‐tuning growth factor responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the oncologic setting, SPRY1’s regulatory influence on MAPK and related downstream pathways has been linked to diverse tumor phenotypes. In several cancers—including prostate, colorectal, Ewing sarcoma, rhabdomyosarcoma, ovarian malignancies, and even subsets of triple‐negative breast cancer—deregulated SPRY1 expression (often through promoter hypermethylation or microRNA‐mediated silencing) disrupts the normal feedback inhibition of RAS–MAPK signaling. In some cell types, this loss or repression of SPRY1 promotes aberrant proliferation, epithelial–mesenchymal transition or altered differentiation, while in other contexts SPRY1 re‐expression can limit tumorigenicity. Such studies underscore its context‐dependent tumor suppressor (and in certain cases oncogenic) roles, as well as its interplay with other signaling modulators and microRNAs that collectively influence malignant progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond development and cancer, SPRY1 plays key roles in tissue homeostasis, repair, and inflammatory responses. In muscle and adipose stem/progenitor cells, age‐associated epigenetic repression of SPRY1 impairs stem cell quiescence and differentiation, thereby reducing regenerative capacity. In vascular and endothelial cells, modulation of SPRY1 influences cell proliferation, neointimal hyperplasia, and angiogenic responses. Moreover, in inflammatory settings – for example, in chondrocytes, synoviocytes, keratinocytes, and periodontal ligament cells – alterations in the microRNA–SPRY1 axis contribute to changes in apoptosis, extracellular matrix integrity, and immune signaling. Collectively, these observations position SPRY1 as a critical mediator linking MAPK pathway activity to cellular senescence, differentiation, and homeostatic control in diverse tissues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "James E Egan, Amy B Hall, Bogdan A Yatsula, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.052090899"}], "href": "https://doi.org/10.1073/pnas.052090899"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11983899"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11983899"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Liu Wang, Chaoneng Ji, Hai Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and expression analysis of a novel splice variant of human Sprouty1 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14533010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14533010"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "E Y Anteby, S Natanson-Yaron, C Greenfield, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human placental Hofbauer cells express sprouty proteins: a possible modulating mechanism of villous branching."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Placenta (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.placenta.2004.08.008"}], "href": "https://doi.org/10.1016/j.placenta.2004.08.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15950061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15950061"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Andrea Faedo, Ugo Borello, John L R Rubenstein "}, {"type": "b", "children": [{"type": "t", "text": "Repression of Fgf signaling by sprouty1-2 regulates cortical patterning in two distinct regions and times."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.0307-10.2010"}], "href": "https://doi.org/10.1523/JNEUROSCI.0307-10.2010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20237272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20237272"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "S Fritzsche, M Kenzelmann, M J Hoffmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Relat Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/erc.1.01190"}], "href": "https://doi.org/10.1677/erc.1.01190"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16954433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16954433"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Gerben Schaaf, Mohamed Hamdi, Danny Zwijnenburg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-2532"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-2532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20068162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20068162"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Alexander Henke, O Cathal Grace, George R Ashley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0042516"}], "href": "https://doi.org/10.1371/journal.pone.0042516"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22880013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22880013"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bhumika Sharma, Sonali Joshi, Antonella Sassano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.400721"}], "href": "https://doi.org/10.1074/jbc.M112.400721"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23074222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23074222"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Q Zhang, T Wei, K Shim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2015.365"}], "href": "https://doi.org/10.1038/onc.2015.365"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26434583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26434583"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Elizabeth T Wiles, Bianca Lui-Sargent, Russell Bell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0059369"}], "href": "https://doi.org/10.1371/journal.pone.0059369"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23527175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23527175"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "F Cidre-Aranaz, T G P Grünewald, D Surdez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2016.244"}], "href": "https://doi.org/10.1038/onc.2016.244"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27375017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27375017"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Qing He, Hongyu Jing, Lucy Liaw, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep23216"}], "href": "https://doi.org/10.1038/srep23216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26976794"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26976794"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Naoki Terada, Takumi Shiraishi, Yu Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.24805"}], "href": "https://doi.org/10.1002/jcb.24805"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24604720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24604720"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Bernard Kwabi-Addo, Chengxi Ren, Michael Ittmann "}, {"type": "b", "children": [{"type": "t", "text": "DNA methylation and aberrant expression of Sprouty1 in human prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenetics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/epi.4.1.7400"}], "href": "https://doi.org/10.4161/epi.4.1.7400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19164898"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19164898"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Samar Masoumi-Moghaddam, Afshin Amini, Anahid Ehteda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Ovarian Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1757-2215-7-61"}], "href": "https://doi.org/10.1186/1757-2215-7-61"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24932220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24932220"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ahmed H Mekkawy, Charles E De Bock, Zhen Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel protein interactors of urokinase-type plasminogen activator receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.08.010"}], "href": "https://doi.org/10.1016/j.bbrc.2010.08.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20696135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20696135"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "M Darimipourain, S Wang, M Ittmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate Cancer Prostatic Dis (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/pcan.2011.33"}], "href": "https://doi.org/10.1038/pcan.2011.33"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21826097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21826097"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jun Sung Lee, Ji Eun Lee, Yu Mi Oh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recruitment of Sprouty1 to immune synapse regulates T cell receptor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0803799"}], "href": "https://doi.org/10.4049/jimmunol.0803799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19915061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19915061"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Marko Vidak, Ivana Jovcevska, Neja Samec, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms19051369"}], "href": "https://doi.org/10.3390/ijms19051369"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29734672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29734672"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Anna Zita Mehira Kamptner, Christoph-Erik Mayer, Hedwig Sutterlüty "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty3, but Not Sprouty1, Expression Is Beneficial for the Malignant Potential of Osteosarcoma Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms222111944"}], "href": "https://doi.org/10.3390/ijms222111944"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34769378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34769378"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Bo Qiu, E Yang, Yulian Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between SPRY1 and TET3 in skin photoaging and natural aging mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cosmet Dermatol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jocd.16115"}], "href": "https://doi.org/10.1111/jocd.16115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38054565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38054565"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Anne Bigot, William J Duddy, Zamalou G Ouandaogo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Age-Associated Methylation Suppresses SPRY1, Leading to a Failure of Re-quiescence and Loss of the Reserve Stem Cell Pool in Elderly Muscle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2015.09.067"}], "href": "https://doi.org/10.1016/j.celrep.2015.09.067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26526994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26526994"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Xuehui Yang, Yan Gong, Yuefeng Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spry1 and Spry4 differentially regulate human aortic smooth muscle cell phenotype via Akt/FoxO/myocardin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0058746"}], "href": "https://doi.org/10.1371/journal.pone.0058746"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23554919"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23554919"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Nan Yang, Yang Li, Guang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor necrosis factor-α suppresses adipogenic and osteogenic differentiation of human periodontal ligament stem cell by inhibiting miR-21/Spry1 functional axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Differentiation (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.diff.2017.08.004"}], "href": "https://doi.org/10.1016/j.diff.2017.08.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28946056"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28946056"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "A Macià, M Vaquero, M Gou-Fàbregas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2013.161"}], "href": "https://doi.org/10.1038/cdd.2013.161"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24270409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24270409"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Sangjin Lee, Tri M Bui Nguyen, Dmitry Kovalenko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-009-0359-z"}], "href": "https://doi.org/10.1007/s11010-009-0359-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20054616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20054616"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Zhen Lu, Feng Wang, Pei Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Vascul Pharmacol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.vph.2018.01.006"}], "href": "https://doi.org/10.1016/j.vph.2018.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29398368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29398368"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Markus Mandl, Sonja A Wagner, Florian M Hatzmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty1 is a weight-loss target gene in human adipose stem/progenitor cells that is mandatory for the initiation of adipogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1657-3"}], "href": "https://doi.org/10.1038/s41419-019-1657-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31138786"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31138786"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Mingli Feng, Lin Jing, Jingbo Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0020093 ameliorates IL-1β-induced apoptosis and extracellular matrix degradation of human chondrocytes by upregulating SPRY1 via targeting miR-23b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-021-04186-2"}], "href": "https://doi.org/10.1007/s11010-021-04186-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34046827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34046827"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Ping Wang, Yuan Zhou, Jian-Qiang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of Sprouty1 in the proliferation, differentiation and apoptosis of epidermal keratinocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.12477"}], "href": "https://doi.org/10.1111/cpr.12477"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30039569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30039569"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Rosana Maria Kral, Christoph-Erik Mayer, Vanita Vanas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Funct (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbf.2976"}], "href": "https://doi.org/10.1002/cbf.2976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23616430"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23616430"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Xuehui Yang, Yan Gong, Qing He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.26486"}], "href": "https://doi.org/10.1002/jcb.26486"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29105817"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29105817"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "E Yang, Zhao Juan, Zhang Hengshu "}, {"type": "b", "children": [{"type": "t", "text": "Mechanism of SPRY1 methylation regulating natural aging of skin epidermal cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cosmet Dermatol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jocd.13126"}], "href": "https://doi.org/10.1111/jocd.13126"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31483543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31483543"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "F Jiang, H-Y Zhou, L-F Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-421 promotes inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis by targeting SPRY1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201910_19125"}], "href": "https://doi.org/10.26355/eurrev_201910_19125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31646548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31646548"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Markus Mandl, Sonja A Wagner, Florian M Hatzmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty1 Prevents Cellular Senescence Maintaining Proliferation and Differentiation Capacity of Human Adipose Stem/Progenitor Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gerontol A Biol Sci Med Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/gerona/glaa098"}], "href": "https://doi.org/10.1093/gerona/glaa098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32304210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32304210"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Zahia Touat-Hamici, Malorie Blancard, Ruifang Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A SPRY1 domain cardiac ryanodine receptor variant associated with short-coupled torsade de pointes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-021-84373-9"}], "href": "https://doi.org/10.1038/s41598-021-84373-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33664309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33664309"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Yuan Zhou, Ping Wang, Xue-Yan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.13290"}], "href": "https://doi.org/10.1111/cpr.13290"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35716036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35716036"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Jing Wang, Zhenning Wang, Meng Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0099630 Participates in SPRY1-Mediated Repression in Periodontitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Dent J (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.identj.2022.06.025"}], "href": "https://doi.org/10.1016/j.identj.2022.06.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35933226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35933226"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Xuehui Yang, Chenhao Yang, Robert E Friesel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sprouty1 has a protective role in atherogenesis and modifies the migratory and inflammatory phenotype of vascular smooth muscle cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2023.04.007"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2023.04.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37121163"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37121163"}]}]}]}
|
| Synonyms | HSPRY1 |
| Proteins | SPY1_HUMAN |
| NCBI Gene ID | 10252 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SPRY1 has 9,280 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 115 datasets.
Click the + buttons to view associations for SPRY1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPRY1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPRY1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPRY1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving SPRY1 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SPRY1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPRY1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPRY1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SPRY1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPRY1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SPRY1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SPRY1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SPRY1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SPRY1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SPRY1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SPRY1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPRY1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SPRY1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SPRY1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SPRY1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SPRY1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SPRY1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SPRY1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SPRY1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SPRY1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DEPOD Substrates of Phosphatases | phosphatases that dephosphorylate SPRY1 protein from the curated DEPOD Substrates of Phosphatases dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SPRY1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SPRY1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SPRY1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SPRY1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SPRY1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SPRY1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SPRY1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SPRY1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SPRY1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SPRY1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SPRY1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SPRY1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SPRY1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SPRY1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SPRY1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SPRY1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SPRY1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPRY1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SPRY1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SPRY1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SPRY1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SPRY1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SPRY1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SPRY1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SPRY1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SPRY1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SPRY1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SPRY1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SPRY1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SPRY1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SPRY1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SPRY1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SPRY1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with SPRY1 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SPRY1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SPRY1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SPRY1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SPRY1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SPRY1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving SPRY1 protein from the KEGG Pathways dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPRY1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SPRY1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SPRY1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SPRY1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SPRY1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SPRY1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPRY1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SPRY1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SPRY1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SPRY1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SPRY1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SPRY1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SPRY1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| PANTHER Pathways | pathways involving SPRY1 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SPRY1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SPRY1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SPRY1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SPRY1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SPRY1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SPRY1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SPRY1 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SPRY1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SPRY1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPRY1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SPRY1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SPRY1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SPRY1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SPRY1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of SPRY1 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Gene Perturbations | gene perturbations changing phosphorylation of SPRY1 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Gene Perturbations dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of SPRY1 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SPRY1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SPRY1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SPRY1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SPRY1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SPRY1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SPRY1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SPRY1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SPRY1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SPRY1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SPRY1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SPRY1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SPRY1 protein from the WikiPathways Pathways 2024 dataset. | |